Genekam Biotechnology AG is working on a complex type of therapy development to prevent and cure viral diseases, but by chance we found a simple and inexpensive therapeutic option against coronavirus as described below.

Genekam Biotechnology AG has developed a potent antiviral solution called Genekampowermolecule, which is in the position to prevent coronavirus infection if it is taken before and after attending a large gathering, visiting a crowded area like malls or the hospital as examples. It is in the position to treat vaccinated and nonvaccinated persons suffering from coronavirus infection and reinfection, where it reduces the painful throat itching and headache immediately (within 1-3 hours) after the oral administration. There is the reduction of other symptoms, e.g., coughing, joint pains, as well as pressure on the ears, along with providing the sound sleep. It leads to a very fast recovery in a full-blown infection.

All persons who took this molecule before traveling do not get any infection after the air as well as rail travel, but one person, who did not take this molecule before traveling to a long-distance flight, has become ill with coronavirus infection in spite of the fact the same person was vaccinated. The same person took this molecule during the same flight later and did not get any infection. This is an example. A person who has always taken this molecule while traveling to the USA (3 times in this year 2024) and to the UK (one time) did not get any coronavirus infection, in spite of the fact that this person used public transportation in New York and Washington, DC, along with London, UK.. This is another example.

Genekampowermolecule is developed from a natural source, and it is pasted in the oral cavity. It has shown rarely any side effects during the oral administration; however, persons with a high degree of allergy should not take this molecule without undergoing the testing. Till today, we have never seen any case of toxicity of this molecule. Its production cost is very low, and it can be made available to the whole world.

We have been working on this molecule for 4 years. Now we are working to find out whether this can be placed on the market as OTC or a drug, where large clinical studies are needed. One of the best applications of this molecule is to prevent infection. It means people traveling around the world can use them before travel, e.g., airlines, drivers of trains or buses, etc. Similarly, police as well as the army can use this molecule to prevent the coronavirus infection.